{"id":"W3092162886","doi":"10.1186/s12931-020-01513-x","title":"CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma","year":2020,"lang":"en","type":"article","venue":"Respiratory Research","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca; Amgen","keywords":"Medicine; Thymic stromal lymphopoietin; Asthma; Placebo; Airway; Allergy; Clinical endpoint; Internal medicine; Immunology; Eosinophilic; Randomized controlled trial; Pathology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001825293,0.002239225,0.002816071,0.0006006145,0.0006862522,0.001181799,0.001275628,0.002239898,0.01220846],"category_scores_gemma":[0.002151957,0.0006099226,0.001550125,0.0004175087,0.001295918,0.001668827,0.0005701871,0.002683643,0.001293868],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008667306,"about_ca_system_score_gemma":0.00187322,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001242339,"about_ca_topic_score_gemma":0.002814923,"domain_scores_codex":[0.9992711,0.0002938354,0.00003867039,0.0001795803,0.00008430143,0.0001324041],"domain_scores_gemma":[0.9990281,0.0002178044,0.0002359645,0.00006597883,0.00008966269,0.0003624893],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9698083,0.007332346,0.0005382589,0.001210938,0.0005235458,0.00007111309,0.00006243591,0.0002848389,0.004350593,0.0002270741,0.00154465,0.01404574],"study_design_scores_gemma":[0.9610301,0.03726311,0.0008278258,0.0000218098,0.0001169882,0.00002715053,0.00001050859,0.0001655675,0.0001254776,0.00006820932,0.0003354236,0.000007924476],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9693551,0.006972493,0.00109485,0.001404114,0.0009133927,0.01349651,0.002525833,0.0003249858,0.003912688],"genre_scores_gemma":[0.9675682,0.003484162,0.003737561,0.002302569,0.001083969,0.01548806,0.002165332,0.00004611338,0.00412401],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01220846,"threshold_uncertainty_score":0.0408414,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04846511786439189,"score_gpt":0.3771722020565846,"score_spread":0.3287070841921927,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}